SET AND READY TO UNLEASH THE POTENTIAL OF THE PHARMACIST HEALTH WORKFORCE Government aligns Scope of Practice review with Pharmacists in 2030 report
Filmed in Perth, Western Australia, November 2024
With Associate Professor Fei Sim, National President
Pharmaceutical Society of Australia (PSA)
Last week, Associate Professor Fei Sim the National President of the Pharmaceutical Society of Australia (PSA), the peak body representing 39,000 pharmacists across Australia’s health system, spoke to Australian Health Journal about the release of the Unleashing the Potential of our Health Workforce – Scope of Practice Review. The review and final report sets out to create a clear pathway for health professionals to contribute more to our health system and practice to their full and top of scope.
The report calls for governments to remove the inconsistent barriers that restrict the scope of healthcare professionals, including pharmacists.
PSA National President Associate Professor Fei Sim FPS commended the report’s focus on removing barriers for pharmacists and other healthcare professionals as a critical step towards a more accessible and resilient healthcare system.
“This review confirms PSA’s view that inconsistent regulations, unnecessary restrictions on practice, and siloed workforces are having a negative impact on patient access to quality health care,” Associate Professor Sim said.
“Pharmacists are some of the most accessible healthcare professionals in our communities, yet regulatory barriers continue to limit our ability to provide care when and where our patients need it. The release of this final report is the next step towards breaking down these barriers through a short- and long-term reform agenda, addressing the inefficiencies in our health system.”
Associate Professor Sim said that the report’s recommendations present a genuine opportunity to improve access to health care across Australia.
“There is a clear alignment between Cormack’s recommendations and the actions in PSA’s vision for the pharmacy profession, Pharmacists in 2030. Both present a clear vision for the future that requires collaboration for a health system that works for patients,” Associate Professor Sim said.
“This report recognises the core role of pharmacies and pharmacists as primary healthcare providers and recommends a multidisciplinary approach to patient care.
“In order to make the most of the opportunities presented by the report, we need governments, regulators and health care professionals to work together for a strong, sustainable health system that utilises all health professionals to their full scope.
“I urge governments and stakeholders at all levels to accept and act on the report’s recommendations in full to build a health system ready for the growing health needs of Australians.”
A/Prof Fei Sim served on the Cormack Review’s Expert Advisory Committee, representing the pharmacy profession.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
-
The desire for primary care nurses to do more, be recognised and valued for the work they do
Denise Lyons is a highly experienced nurse with over 40 years in the profession, including more than 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centred care that improves the health and wellbeing of her community.
-
Practising to top scope of urology practice, advancing treatment & patient care through research
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
